1-5 of 5
Antonio de Vivo, MD
Close
Sort by
Journal Articles

Clinical and Prognostic Relevance of Magnetic Resonance Imaging of the Spine in Newly Diagnosed Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation.

Patrizia Tosi, MD, Elena Zamagni, MD, Paola Tacchetti, MD, Eugenio Salizzoni, MD, Giulia Perrone, MD, Michela Ceccolini, MD, Annamaria Brioli, MD, Maria C. Pallotti, MD, Lucia Pantani, MD, Antonio de Vivo, MD, Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2007) 110 (11): 4728.
https://doi.org/10.1182/blood.V110.11.4728.4728
Published: 2007
Journal Articles

Rituximab Combined with M/VACOP-B and Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL): A Prospective Italian Phase II IIL Study.

Maurizio Martelli, MD, Vittorio Stefoni, MD, Giuseppina Cabras, MD, Sergio Cortellazzo, MD, Ercole Brusamolino, MD, Alessandro Levis, MD, Barbara Botto, MD, Antonio De Vivo, MD, Fiammetta Natalino, MD, Finolezzi Erica, MD, Robert Foa, MD, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2006) 108 (11): 4697.
https://doi.org/10.1182/blood.V108.11.4697.4697
Published: 2006
Journal Articles

Fludarabine Based Regimen (FLAI) Is an Effective Treatment for Induction of Multidrug Resistant Pgp-Positive Acute Myeloid Leukemia Patients.

Domenico Russo, MD, Daniela Damiani, MD, Michele Malagola, MD, Antonio De Vivo, MD, Mauro Fiacchini, MD, Giovanni Martinelli, MD, Pier Paolo Piccaluga, MD, Anna Candoni, MD, Angela Michelutti, MD, Renato Fanin, MD, Maurizio Castelli, MD, Nicoletta Testoni, MD, Emanuela Ottaviani, MD, Michela Rondoni, MD, Giancarla Pricolo, MD, Patrizio Mazza, MD, Eliana Zuffa, MD, Alfonso Zaccaria, MD, Donatella Raspadori, MD, Monica Bocchia, MD, Francesco Lauria, MD, Alessandro Bonini, MD, Paolo Avanzini, MD, Luigi Gugliotta, MD, Ivana Pierri, MD, Marco Gobbi, MD, Giuseppe Visani, MD, Michele Baccarani, MD
Journal: Blood
Blood (2005) 106 (11): 1857.
https://doi.org/10.1182/blood.V106.11.1857.1857
Published: 2005
Journal Articles

Superior Complete Remission/Very Good Partial Remission Rate with Peri-Transplant Administration of Thalidomide-Dexamethasone for Newly Diagnosed Multiple Myeloma.

Michele Cavo, MD, Elena Zamagni, MD, Patrizia Tosi, MD, Delia Cangini, MD, Paola Tacchetti, MD, Claudia Cellini, MD, Nicoletta Testoni, PhD, Chiara Nicci, PhD, Antonio de Vivo, MD, Giulia Perrone, MD, Michela Ceccolini, MD, Michele Baccarani, MD
Journal: Blood
Blood (2005) 106 (11): 5474.
https://doi.org/10.1182/blood.V106.11.5474.5474
Published: 2005
Journal Articles

Imatinib in the Treatment of CML Patients ≥ 65 Years Old in Late Chronic Phase: Results of a Phase II Study of the GIMEMA CML Working Party.

Simona Bassi, MD, Fausto Castagnetti, MD, Marilina Amabile, BD, Barbara Giannini, BD, Daniela Cilloni, MD, Barbara Izzo, BD, Antonio De Vivo, MD, Simona Luatti, BD, Nicoletta Testoni, BD, Giovanna Rege-Cambrin, MD, Ilaria Iacobucci, BD, Enrico Gottardi, BD, Fabrizio Pane, MD, Francesco Salvatore, MD, Alessandra Dorigo, MD, Giuseppe Saglio, MD, Giovanni Martinelli, MD, Gianantonio Rosti, MD, Michele Baccarani, MD
Journal: Blood
Blood (2004) 104 (11): 2935.
https://doi.org/10.1182/blood.V104.11.2935.2935
Published: 2004